FRX Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Fennec Pharmaceuticals Inc

Watchlist Manager

Watchlist

Price: 15.43 CAD Market Closed

Market Cap: CA$421.6m

F	Fennec Pharmaceuticals Inc TSX:FRX	US
	Workspace Group PLC LSE:WKP	UK
S	SIS Distribution Thailand PCL SET:SIS	TH
	Asahi Net Inc TSE:3834	JP
	Acquazzurra SpA MIL:ACQ	IT
	NVIDIA Corp SIX:NVDA	US
	Elis SA PAR:ELIS	FR
	Solstad Maritime ASA F:O6O	NO

Profitability Summary

Fennec Pharmaceuticals Inc's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Exceptional Gross Margin

94%

Strong 3Y Average Gross Margin

93%

Declining Gross Margin

95% > 94%

Negative Operating Margin

-5%

Negative 3Y Average Operating Margin

-22%

Operating Margin is Increasing

-131% > -5%

Negative Net Margin

-5%

Negative 3Y Average Net Margin

-30%

Net Margin is Increasing

-155% > -5%

Negative Free Cash Flow Margin

-3%

Negative 3Y Average Free Cash Flow Margin

-14%

Free Cash Flow Margin is Increasing

-146% > -3%

Negative ROE

-19%

Exceptional 3Y Average ROE

Negative 3Y Average ROIC

-168%

ROIC is Increasing

-1.869% > -13%

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.